OrbiMed Asia leads Series A round for CBT Pharmaceuticals
Santa Clara, California-based CBT Pharmaceuticals, a developer of cancer treatments, has raised $9.75 million in Series A financing. OrbiMed Asia led the round.
29 August 2016•1 min read
Santa Clara, California-based CBT Pharmaceuticals, a developer of cancer treatments, has raised $9.75 million in Series A financing. OrbiMed Asia led the round.
